DARA BioSciences, Inc. Awarded Grants Totaling Approximately $500,000 for Its Two Drugs Advancing Through Clinical Studies

RALEIGH, N.C., Nov. 2, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences (Nasdaq:DARA) announced today grant approvals by the Internal Revenue Service under the Patient Protection and Affordable Care Act of 2010 for KRN5500 and DB959 in the amount of approximately $500,000 for the calendar year 2009.